Platelet-Based Breast Implant Contracture Relaxation Without Surgery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Capsular contractures around breast implants, particularly grades 3 and 4, cause significant pain and deformity, necessitating surgical intervention, and existing treatments like capsulectomy or capsulotomy are invasive.

Innovation Solution

Administering autologous platelet-rich plasma (PRP) or platelet-rich fibrin (PRF) products to the capsular contracture, combined with acoustic sound waves or pulsed electric currents, to promote relaxation and reduce contracture severity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If surgical intervention (capsulectomy or capsulotomy) is performed to treat capsular contracture, then the contracture is removed or released, but the treatment is invasive and carries surgical risks

Engineering Contradiction:
Improveeffectiveness of contracture treatmentVSAvoidinvasiveness and surgical risks
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces mechanical surgical intervention with a biochemical treatment system. Platelet-rich plasma (PRP) or platelet-rich fibrin (PRF) is injected into the capsular contracture, utilizing biological factors (growth factors, cytokines) to relax the fibrotic capsule rather than mechanically removing or incising it. This substitution eliminates surgical invasiveness while maintaining treatment effectiveness.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces platelet-rich plasma or platelet-rich fibrin as an intermediary substance between the treatment goal and the capsular contracture. These platelet-based products serve as mediators that deliver therapeutic factors directly to the contractured tissue, enabling non-invasive relaxation of the capsule through biochemical mechanisms rather than direct surgical manipulation.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Area of stationary object

If platelet-based product is injected and spread manually, then the product reaches the contracture tissue, but the distribution may be uneven

Engineering Contradiction:
Improvecoverage area of platelet productVSAvoiduniformity of product distribution
Core Design Contradiction:
Area of stationary objectVSManufacturing precision

Solution Approach 1:

The patent employs acoustic sound waves (ultrasound) to enhance the distribution of injected platelet-based products. The acoustic energy creates mechanical vibrations that promote uniform dispersion of the PRP or PRF throughout the capsular contracture tissue, ensuring even coverage and maximizing therapeutic effect across the entire treated area.

Inventive Principle:
Principle #18Mechanical vibration

3Reliability

If multiple treatment sessions are administered, then the contracture relaxation is enhanced, but the treatment time increases

Engineering Contradiction:
Improvecontracture relaxation effectVSAvoidtreatment duration
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent employs periodic treatment sessions spaced one to two weeks apart, delivering platelet-based products in controlled intervals. This periodic administration allows cumulative therapeutic effects to build while maintaining optimal platelet activity levels, achieving enhanced contracture relaxation through repeated biochemical stimulation rather than a single prolonged intervention.

Inventive Principle:
Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method effectively reduces capsular contracture severity by at least one Baker grade within 30 days, providing a less invasive alternative to surgical interventions.

Implementation Method 1

spreading the injected platelet-based product under the skin by manipulation with or without application of acoustic sound waves

Methodology Applied
Scientific EffectAcoustic sound waves: Ultrasound

Implementation Method 2

applying the platelet-based product to the patient's skin adjacent to said capsular contracture and inducing the transdermal absorption of the platelet-based product into the skin with pulsed electric currents

Methodology Applied
Scientific EffectPulsed electric currents: Electrophoresis

Data Source

PatentUS12521417B2Use of platelet-based products for treatment of capsular contracture proximate breast implant
Publication Date: 2026.01.13 L & O MEDICAL LLC
  • US12521417B2 patent drawing
  • US12521417B2 patent drawing

AI summary

Methods and products for treating capsular contractures of breast implants including (1) obtaining a platelet-rich plasma (PRP) or platelet-rich fibrin (PRF) fraction from a patient who exhibits capsular contracture of a breast implant; and (2) applying the PRP or PRF fraction to said capsular contracture, thereby relaxing the capsular contracture.